Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olr1063 Inhibitors

Olr1063 inhibitors are a specialized class of chemical compounds designed to specifically target and inhibit the activity of the Olr1063 protein, an olfactory receptor belonging to the extensive G-protein-coupled receptor (GPCR) superfamily. These receptors, including Olr1063, play a crucial role in the olfactory system by detecting odorant molecules and initiating the signal transduction pathways that lead to the perception of smell. Olr1063 is expressed in the membranes of olfactory sensory neurons located in the nasal epithelium. When an odorant binds to Olr1063, the receptor undergoes a conformational change that activates an intracellular signaling cascade mediated by G-proteins. This cascade ultimately results in the generation of an electrical signal that is transmitted to the brain, where it is interpreted as a specific odor. Inhibitors of Olr1063 are typically small molecules that are designed to bind to the receptor's odorant-binding site or other critical regions, thereby blocking the receptor's ability to interact with its natural ligands. This inhibition prevents the receptor from initiating the olfactory signal transduction process, effectively modulating the perception of specific smells.

The development of Olr1063 inhibitors requires a comprehensive understanding of the receptor's structural biology and the molecular interactions that are essential for its function. Researchers often employ high-throughput screening techniques to identify initial lead compounds that demonstrate inhibitory potential against Olr1063. These lead compounds are then refined through structure-activity relationship (SAR) studies, where their chemical structures are systematically modified to enhance binding affinity, specificity, and stability within the receptor's binding pocket. The chemical structures of Olr1063 inhibitors are diverse, often incorporating functional groups that facilitate strong and specific interactions with the receptor, such as hydrogen bonding, hydrophobic interactions, and van der Waals forces. Advanced structural biology techniques like X-ray crystallography and nuclear magnetic resonance (NMR) spectroscopy are employed to visualize these interactions at an atomic level, providing critical insights that guide the design and optimization of these inhibitors. Achieving high selectivity is a crucial objective in the development of Olr1063 inhibitors, ensuring that these compounds specifically target Olr1063 without affecting other olfactory receptors or GPCRs that share similar structural features. This selectivity is essential for enabling precise modulation of Olr1063 activity, allowing researchers to explore its specific role in olfactory perception and to deepen their understanding of the molecular mechanisms underlying the sense of smell.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$57.00
$100.00
$250.00
129
(3)

Inhibits multiple kinases, potentially affecting signaling pathways connected to Olr1063's function.

Sunitinib, Free Base

557795-19-4sc-396319
sc-396319A
500 mg
5 g
$153.00
$938.00
5
(0)

Targets VEGFR and PDGFR, potentially influencing pathways relevant to Olr1063 activity.

Gefitinib

184475-35-2sc-202166
sc-202166A
sc-202166B
sc-202166C
100 mg
250 mg
1 g
5 g
$63.00
$114.00
$218.00
$349.00
74
(2)

EGFR inhibitor, could impact signaling pathways intersecting with Olr1063.

Imatinib

152459-95-5sc-267106
sc-267106A
sc-267106B
10 mg
100 mg
1 g
$26.00
$119.00
$213.00
27
(1)

BCR-ABL, c-Kit, PDGFR inhibitor, might affect Olr1063 through modulated signaling pathways.

Afatinib

439081-18-2sc-364398
sc-364398A
5 mg
10 mg
$114.00
$198.00
13
(2)

Irreversible EGFR inhibitor, could alter pathways related to Olr1063 activity.

Dasatinib

302962-49-8sc-358114
sc-358114A
25 mg
1 g
$70.00
$145.00
51
(1)

BCR-ABL and Src family kinases inhibitor, potentially modulating pathways affecting Olr1063.

XL-184 free base

849217-68-1sc-364657
sc-364657A
5 mg
10 mg
$94.00
$208.00
1
(1)

Targets MET, VEGFR, and RET kinases, potentially affecting Olr1063 through various signaling pathways.

Lenvatinib

417716-92-8sc-488530
sc-488530A
sc-488530B
5 mg
25 mg
100 mg
$182.00
$661.00
$1690.00
3
(0)

Inhibits VEGFR, FGFR, PDGFR, RET, and KIT, could modulate signaling pathways intersecting with Olr1063.

AP 24534

943319-70-8sc-362710
sc-362710A
10 mg
50 mg
$175.00
$983.00
2
(1)

Targets BCR-ABL and other kinases, potentially influencing Olr1063 activity via related signaling pathways.

Osimertinib

1421373-65-0sc-507355
5 mg
$86.00
(0)

EGFR inhibitor, might affect Olr1063 signaling through EGFR pathway modulation.